EPRONTIA™已被批准作为单一疗法,用于治疗2岁及以上患者的部分发作或原发性全身强直-阵挛发作;作为辅助疗法,用...查看全文
美港电讯APP2021-08-06 16:28
$Eton Pharmaceuticals(ETON)$ 盘前涨10.4%,美国食品药品监督管理局(FDA)今日将审核是否批准Eton Pharmaceuticals治疗癫痫的口服新药。(来自美港电讯APP)查看全文
$Eton Pharmaceuticals(ETON)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-20-008763 Act: 34 Size: 3 MB 网页链接
$Eton Pharmaceuticals(ETON)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-20-008752 Act: 34 Size: 157 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-20-007957 Act: 34 Size: 43 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 8-K Current report, items 1.01, 2.03, and 9.01 Accession Number: 0001493152-20-007843 Act: 34 Size: 1 MB 网页链接
$Eton Pharmaceuticals(ETON)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-20-007595 Act: 34 Size: 37 KB 网页链接
$Eton Pharmaceuticals(ETON)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001493152-20-006939 Act: 34 Size: 617 KB 网页链接
$Eton Pharmaceuticals(ETON)$ DEF 14A Other definitive proxy statements Accession Number: 0001493152-20-006934 Act: 34 Size: 516 KB 网页链接
$Eton Pharmaceuticals(ETON)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001493152-20-006039 Act: 33 Size: 9 KB 网页链接
$Eton Pharmaceuticals(ETON)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001493152-20-005929 Act: 34 Size: 164 KB 网页链接
$Eton Pharmaceuticals(ETON)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001493152-20-005927 Size: 5 KB 网页链接